Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RELiZORB (100300/100301)

K-Number: K250499 · 2025-04-17

ApplicantAlcresta Therapeutics, Inc.
Decision Date2025-04-17
Product CodePLQ
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

RELiZORB (100300/100301) is the device name listed in this FDA 510(k) record. The listed applicant is Alcresta Therapeutics, Inc.. It received FDA 510(k) clearance on 2025-04-17 under 510(k) number K250499. The device is classified under product code PLQ. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RELiZORB (100300/100301)?

RELiZORB (100300/100301) is a medical device that received FDA 510(k) clearance on 2025-04-17. The listed applicant is Alcresta Therapeutics, Inc.. The 510(k) number is K250499.

When did RELiZORB (100300/100301) receive FDA 510(k) clearance?

RELiZORB (100300/100301) received FDA 510(k) clearance on 2025-04-17, under 510(k) number K250499.

Who is the listed applicant for RELiZORB (100300/100301)?

The FDA 510(k) record lists Alcresta Therapeutics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RELiZORB (100300/100301)?

The FDA product code for RELiZORB (100300/100301) is PLQ.

Other records listing Alcresta Therapeutics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K243284RELiZORB (100300/ 100301)K232784RELiZORB®K231156Enzyme Packed Cartridge - RELiZORBK191379RELiZORBK163057RelizorbK161247Relizorb

View all 7 devices →

Related Devices (Code: PLQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K243284RELiZORB (100300/ 100301)Alcresta Therapeutics, Inc.K232784RELiZORB®Alcresta Therapeutics, Inc.K231156Enzyme Packed Cartridge - RELiZORBAlcresta Therapeutics, Inc.K191379RELiZORBAlcresta Therapeutics, Inc.K163057RelizorbAlcresta Therapeutics, Inc.K161247RelizorbAlcresta Therapeutics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑